Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Can Fite Biopharma Ltd Company Profile (NASDAQ:CANF)

Consensus Ratings for Can Fite Biopharma Ltd (NASDAQ:CANF) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $2.70 (21.08% upside)

Analysts' Ratings History for Can Fite Biopharma Ltd (NASDAQ:CANF)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/31/2015HC WainrightLower Price TargetBuy$7.00 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
3/30/2015Roth CapitalDowngradeBuy -> Neutral$20.00 -> $2.40ViewTweet This Rating  Share This Rating on StockTwits
3/18/2015Roth CapitalSet Price TargetBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
12/29/2014Roth CapitalLower Price TargetBuy$28.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
11/18/2014HC WainrightInitiated CoverageBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
12/23/2013Roth CapitalBoost Price Target$28.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/1/2013 forward)